SummitTX Capital L.P. Lowers Stake in Acadia Healthcare Company, Inc. $ACHC

Posted by Stanley Muller on Aug 2nd, 2026

SummitTX Capital L.P. cut its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 80.2% during the first quarter, HoldingsChannel reports. The fund owned 11,457 shares of the company’s stock after selling 46,366 shares during the quarter. SummitTX Capital L.P.’s holdings in Acadia Healthcare were worth $268,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in ACHC. EverSource Wealth Advisors LLC lifted its stake in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the last quarter. Wells Fargo & Company MN grew its stake in Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares during the last quarter. Bayforest Capital Ltd purchased a new position in Acadia Healthcare in the fourth quarter valued at about $52,000. Caitong International Asset Management Co. Ltd raised its holdings in Acadia Healthcare by 4,264.8% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after purchasing an additional 5,203 shares in the last quarter. Finally, Parallel Advisors LLC lifted its position in shares of Acadia Healthcare by 857.8% during the first quarter. Parallel Advisors LLC now owns 6,858 shares of the company’s stock valued at $160,000 after buying an additional 6,142 shares during the last quarter.

Acadia Healthcare Stock Performance

ACHC opened at $29.62 on Friday. The company has a market cap of $2.76 billion, a P/E ratio of -2.38, a price-to-earnings-growth ratio of 9.84 and a beta of 0.64. The company has a quick ratio of 1.71, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. The firm’s 50-day moving average price is $28.23 and its 200-day moving average price is $23.74. Acadia Healthcare Company, Inc. has a 52-week low of $11.43 and a 52-week high of $35.83.

Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. The company had revenue of $865.84 million during the quarter, compared to analysts’ expectations of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. Acadia Healthcare’s revenue for the quarter was down .4% on a year-over-year basis. During the same period last year, the business earned $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, equities analysts anticipate that Acadia Healthcare Company, Inc. will post 1.54 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on ACHC. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th. KeyCorp increased their target price on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. UBS Group raised their target price on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research note on Thursday, July 9th. Guggenheim lifted their price target on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Acadia Healthcare in a research report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Acadia Healthcare currently has an average rating of “Hold” and an average target price of $29.85.

Check Out Our Latest Stock Analysis on ACHC

Acadia Healthcare Profile

(Free Report)

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.